Interestingly, we found that expression of EMX2, but not PAX6, is markedly upregulated in supratentorial ependymomas compared to ependymomas from other regions of the CNS (37-fold expression difference P<0.0001; Taylor et al, 2005). The gene discussed is PAX6; the disease is ependymoma.